Composite criteria using clinical and FDG PET/CT factors for predictin…
페이지 정보
본문
Kang YK, Choi JY, Paeng JC, Kim YI, Kwon HW, Cheon GJ, Suh KS, Kwon CHD, Lee DS, Kang KW.
- 이전글Use of Molecular Imaging in Clinical Drug Development: a Systematic Review. 20.04.22
- 다음글Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation. 20.04.22
댓글목록
등록된 댓글이 없습니다.